世界の真核生物発現システム市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11889)
◆英語タイトル:Global Eukaryotic Expression Systems Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11889
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは真核生物発現システムの世界市場について調査・分析した資料です。種類別(MEL、COS、CHO、昆虫細胞)の市場規模、用途別(試薬、発現ベクター、コンピテントセル)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別真核生物発現システムの競争状況、市場シェア
・世界の真核生物発現システム市場:種類別市場規模 2015年-2020年(MEL、COS、CHO、昆虫細胞)
・世界の真核生物発現システム市場:種類別市場規模予測 2021年-2026年(MEL、COS、CHO、昆虫細胞)
・世界の真核生物発現システム市場:用途別市場規模 2015年-2020年(試薬、発現ベクター、コンピテントセル)
・世界の真核生物発現システム市場:用途別市場規模予測 2021年-2026年(試薬、発現ベクター、コンピテントセル)
・北米の真核生物発現システム市場分析:米国、カナダ
・ヨーロッパの真核生物発現システム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの真核生物発現システム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の真核生物発現システム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの真核生物発現システム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Thermo Fisher、Sigma Aldrich、Jena Bioscience、New England Biolabs、Takara Bio、Bio Rad、Promega、Agilent、Merck Millipore
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Expression systems are used for the production of protein from recombinant DNA molecules (see Recombinant Proteins). They are of widespread use in industry, health care, and scientific research
Increasing cases of complex diseases such as cancer & other cardiovascular diseases and increasing research & development for therapeutics for such diseases are the main drivers of the growth of the market

Market Analysis and Insights: Global Eukaryotic Expression Systems Market
The global Eukaryotic Expression Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Eukaryotic Expression Systems Scope and Market Size
Eukaryotic Expression Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Eukaryotic Expression Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Thermo Fisher
Sigma Aldrich
Jena Bioscience
New England Biolabs
Takara Bio
Bio Rad
Promega
Agilent
Merck Millipore

Market segment by Type, the product can be split into
MEL
COS
CHO
Insect cells
Market segment by Application, split into
Reagents
Expression vectors
Competent cells

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Eukaryotic Expression Systems Revenue
1.4 Market by Type
1.4.1 Global Eukaryotic Expression Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 MEL
1.4.3 COS
1.4.4 CHO
1.4.5 Insect cells
1.5 Market by Application
1.5.1 Global Eukaryotic Expression Systems Market Share by Application: 2020 VS 2026
1.5.2 Reagents
1.5.3 Expression vectors
1.5.4 Competent cells
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Eukaryotic Expression Systems Market Perspective (2015-2026)
2.2 Global Eukaryotic Expression Systems Growth Trends by Regions
2.2.1 Eukaryotic Expression Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Eukaryotic Expression Systems Historic Market Share by Regions (2015-2020)
2.2.3 Eukaryotic Expression Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Eukaryotic Expression Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Eukaryotic Expression Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Eukaryotic Expression Systems Players by Market Size
3.1.1 Global Top Eukaryotic Expression Systems Players by Revenue (2015-2020)
3.1.2 Global Eukaryotic Expression Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Eukaryotic Expression Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Eukaryotic Expression Systems Market Concentration Ratio
3.2.1 Global Eukaryotic Expression Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Eukaryotic Expression Systems Revenue in 2019
3.3 Eukaryotic Expression Systems Key Players Head office and Area Served
3.4 Key Players Eukaryotic Expression Systems Product Solution and Service
3.5 Date of Enter into Eukaryotic Expression Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Eukaryotic Expression Systems Historic Market Size by Type (2015-2020)
4.2 Global Eukaryotic Expression Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Eukaryotic Expression Systems Market Size by Application (2015-2020)
5.2 Global Eukaryotic Expression Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Eukaryotic Expression Systems Market Size (2015-2020)
6.2 Eukaryotic Expression Systems Key Players in North America (2019-2020)
6.3 North America Eukaryotic Expression Systems Market Size by Type (2015-2020)
6.4 North America Eukaryotic Expression Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Eukaryotic Expression Systems Market Size (2015-2020)
7.2 Eukaryotic Expression Systems Key Players in Europe (2019-2020)
7.3 Europe Eukaryotic Expression Systems Market Size by Type (2015-2020)
7.4 Europe Eukaryotic Expression Systems Market Size by Application (2015-2020)

8 China
8.1 China Eukaryotic Expression Systems Market Size (2015-2020)
8.2 Eukaryotic Expression Systems Key Players in China (2019-2020)
8.3 China Eukaryotic Expression Systems Market Size by Type (2015-2020)
8.4 China Eukaryotic Expression Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Eukaryotic Expression Systems Market Size (2015-2020)
9.2 Eukaryotic Expression Systems Key Players in Japan (2019-2020)
9.3 Japan Eukaryotic Expression Systems Market Size by Type (2015-2020)
9.4 Japan Eukaryotic Expression Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Eukaryotic Expression Systems Market Size (2015-2020)
10.2 Eukaryotic Expression Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Eukaryotic Expression Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Eukaryotic Expression Systems Market Size by Application (2015-2020)

11 India
11.1 India Eukaryotic Expression Systems Market Size (2015-2020)
11.2 Eukaryotic Expression Systems Key Players in India (2019-2020)
11.3 India Eukaryotic Expression Systems Market Size by Type (2015-2020)
11.4 India Eukaryotic Expression Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Eukaryotic Expression Systems Market Size (2015-2020)
12.2 Eukaryotic Expression Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Eukaryotic Expression Systems Market Size by Type (2015-2020)
12.4 Central & South America Eukaryotic Expression Systems Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Details
13.1.2 Thermo Fisher Business Overview
13.1.3 Thermo Fisher Eukaryotic Expression Systems Introduction
13.1.4 Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2015-2020))
13.1.5 Thermo Fisher Recent Development
13.2 Sigma Aldrich
13.2.1 Sigma Aldrich Company Details
13.2.2 Sigma Aldrich Business Overview
13.2.3 Sigma Aldrich Eukaryotic Expression Systems Introduction
13.2.4 Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.2.5 Sigma Aldrich Recent Development
13.3 Jena Bioscience
13.3.1 Jena Bioscience Company Details
13.3.2 Jena Bioscience Business Overview
13.3.3 Jena Bioscience Eukaryotic Expression Systems Introduction
13.3.4 Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.3.5 Jena Bioscience Recent Development
13.4 New England Biolabs
13.4.1 New England Biolabs Company Details
13.4.2 New England Biolabs Business Overview
13.4.3 New England Biolabs Eukaryotic Expression Systems Introduction
13.4.4 New England Biolabs Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.4.5 New England Biolabs Recent Development
13.5 Takara Bio
13.5.1 Takara Bio Company Details
13.5.2 Takara Bio Business Overview
13.5.3 Takara Bio Eukaryotic Expression Systems Introduction
13.5.4 Takara Bio Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.5.5 Takara Bio Recent Development
13.6 Bio Rad
13.6.1 Bio Rad Company Details
13.6.2 Bio Rad Business Overview
13.6.3 Bio Rad Eukaryotic Expression Systems Introduction
13.6.4 Bio Rad Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.6.5 Bio Rad Recent Development
13.7 Promega
13.7.1 Promega Company Details
13.7.2 Promega Business Overview
13.7.3 Promega Eukaryotic Expression Systems Introduction
13.7.4 Promega Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.7.5 Promega Recent Development
13.8 Agilent
13.8.1 Agilent Company Details
13.8.2 Agilent Business Overview
13.8.3 Agilent Eukaryotic Expression Systems Introduction
13.8.4 Agilent Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.8.5 Agilent Recent Development
13.9 Merck Millipore
13.9.1 Merck Millipore Company Details
13.9.2 Merck Millipore Business Overview
13.9.3 Merck Millipore Eukaryotic Expression Systems Introduction
13.9.4 Merck Millipore Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.9.5 Merck Millipore Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Thermo Fisher、Sigma Aldrich、Jena Bioscience、New England Biolabs、Takara Bio、Bio Rad、Promega、Agilent、Merck Millipore

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の真核生物発現システム市場2026:インサイト・予測(Global Eukaryotic Expression Systems Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。